Bo Liu

A Gelatin-Oxidized Dextran Hydrogel for Co-Delivery of γδT Cells and Immunostimulatory Agents Potentiates Local Cancer Immunotherapy.

Current αβT cell-based immunotherapies largely relying on the use of autologous T cells not only face limitations such as complex manufacturing processes, long production cycles, and high costs, but are also susceptible to immune escape due to tumor antigen loss or downregulation. In contrast, γδT cells offer a unique...